Download presentation
Presentation is loading. Please wait.
Published byЕлена Саракаева Modified over 5 years ago
1
Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation Ginna G. Laport, Kevin Sheehan, Jeanette Baker, Randall Armstrong, Ruby M. Wong, Robert Lowsky, Laura J. Johnston, Judith A. Shizuru, David Miklos, Sally Arai, Jonathan E. Benjamin, Wen-Kai Weng, Robert S. Negrin Biology of Blood and Marrow Transplantation Volume 17, Issue 11, Pages (November 2011) DOI: /j.bbmt Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Fluorescence-activated cell sorting analysis of peripheral blood mononuclear cells after 21 days of culture, illustrating the increase in the number of cells expressing CD3+C56+ and CD3+CD314+ phenotypes. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 2 (A) In vitro cytotoxic activity of CIK cells by specific tumor target. Killing of target cell lines including SUDHL-4, OCI-Ly8, DB, and Jurkat at an E:T ratio of 40:1. (B) In vitro cytotoxic activity of CIK cells by each patient against 4 tumor targets—SUDH-L4, OCI-Ly8, DB, and Jurkat—at an E:T ratio of 40:1. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.